Skip to main content
Clinical Trials/NCT03124017
NCT03124017
Completed
Not Applicable

Electronic Alert System Combined With a Risk Score Calculation Tool for Improving Appropriate Thromboprophylaxis in Hospitalized Medical Patients: a Randomized Controlled Trial

Insel Gruppe AG, University Hospital Bern1 site in 1 country1,756 target enrollmentMarch 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Venous Thromboembolism
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
1756
Locations
1
Primary Endpoint
Rate of appropriate thromboprophylaxis
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The investigators aim to investigate whether a computer-based alert system in the electronic patient chart and order entry system using the Geneva Risk Score as clinical decision support tool to estimate the risk of venous thromboembolism improves the rate of appropriate thromboprophylaxis among hospitalized medical patients.

Detailed Description

The use of thromboprophylaxis among acutely ill hospitalized medical patients remains inconsistent. The present study aims to improve the use of appropriate thromboprophylaxis by implementing a computer-based alert system combined with a Geneva Risk Score calculation tool in the electronic patient chart and order entry system. Consecutive acutely ill medical patients without indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment admitted to the medical wards of the University Hospital Bern, Switzerland, will be randomized in a 1:1 fashion to the alert group in which an alert and the Geneva Risk Score calculation tool will be issued in the electronic patient chart or to the control group in which no alert will be issued. The primary endpoint is the rate of appropriate thromboprophylaxis during hospital stay.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
June 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Acutely ill medical patients admitted to medical wards

Exclusion Criteria

  • Indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment

Outcomes

Primary Outcomes

Rate of appropriate thromboprophylaxis

Time Frame: During hospital stay (expected average duration of 1 week)

Secondary Outcomes

  • Rate of correct calculation of the Geneva Risk Score through the calculation tool by the physician in charge(During hospital stay (expected average duration of 1 week))
  • Use of the Geneva Risk Score calculation tool by the physician in charge(During hospital stay (expected average duration of 1 week))

Study Sites (1)

Loading locations...

Similar Trials